Concepts (220)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Femoral Fractures | 7 | 2024 | 376 | 0.910 |
Why?
|
| Femoral Nerve | 1 | 2022 | 39 | 0.870 |
Why?
|
| Psoas Muscles | 1 | 2022 | 71 | 0.850 |
Why?
|
| Periprosthetic Fractures | 4 | 2024 | 62 | 0.840 |
Why?
|
| Fracture Healing | 6 | 2024 | 426 | 0.840 |
Why?
|
| Arthritis, Infectious | 2 | 2024 | 367 | 0.770 |
Why?
|
| Fracture Fixation, Intramedullary | 4 | 2024 | 156 | 0.730 |
Why?
|
| Fractures, Bone | 6 | 2023 | 1945 | 0.640 |
Why?
|
| Streptococcal Infections | 1 | 2021 | 637 | 0.570 |
Why?
|
| Femur Neck | 1 | 2018 | 309 | 0.570 |
Why?
|
| Compartment Syndromes | 3 | 2023 | 153 | 0.530 |
Why?
|
| Shock, Septic | 1 | 2021 | 773 | 0.490 |
Why?
|
| Tibial Fractures | 3 | 2010 | 269 | 0.430 |
Why?
|
| Leukotriene Antagonists | 2 | 2010 | 127 | 0.430 |
Why?
|
| Bone Cysts | 1 | 2012 | 47 | 0.420 |
Why?
|
| Range of Motion, Articular | 2 | 2018 | 1577 | 0.410 |
Why?
|
| Hip Joint | 1 | 2018 | 1002 | 0.390 |
Why?
|
| Shoulder Fractures | 1 | 2012 | 88 | 0.390 |
Why?
|
| Traumatology | 1 | 2011 | 88 | 0.370 |
Why?
|
| Fracture Fixation, Internal | 7 | 2024 | 916 | 0.350 |
Why?
|
| Osteomyelitis | 2 | 2024 | 402 | 0.350 |
Why?
|
| Multiple Trauma | 1 | 2012 | 367 | 0.340 |
Why?
|
| Arachidonic Acid | 1 | 2010 | 434 | 0.340 |
Why?
|
| Leukotrienes | 1 | 2010 | 255 | 0.330 |
Why?
|
| Receptors, Leukotriene | 1 | 2009 | 123 | 0.330 |
Why?
|
| Eicosanoids | 1 | 2010 | 278 | 0.330 |
Why?
|
| Orthopedics | 3 | 2015 | 903 | 0.320 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2010 | 355 | 0.300 |
Why?
|
| Arthroplasty, Replacement, Hip | 3 | 2023 | 1461 | 0.290 |
Why?
|
| Osteotomy | 1 | 2012 | 823 | 0.290 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 3 | 2014 | 164 | 0.280 |
Why?
|
| Hip Prosthesis | 2 | 2023 | 917 | 0.280 |
Why?
|
| Femur | 2 | 2024 | 1297 | 0.280 |
Why?
|
| Bone Transplantation | 1 | 2010 | 907 | 0.260 |
Why?
|
| Osteolysis | 3 | 2014 | 270 | 0.260 |
Why?
|
| Ankle Injuries | 1 | 2008 | 331 | 0.240 |
Why?
|
| Appointments and Schedules | 1 | 2008 | 414 | 0.240 |
Why?
|
| Chondrocytes | 1 | 2009 | 803 | 0.240 |
Why?
|
| Patient Transfer | 1 | 2011 | 760 | 0.240 |
Why?
|
| Trauma Centers | 1 | 2008 | 889 | 0.220 |
Why?
|
| Osteogenesis | 1 | 2009 | 1299 | 0.210 |
Why?
|
| Inflammation Mediators | 1 | 2010 | 1889 | 0.200 |
Why?
|
| Operating Rooms | 1 | 2008 | 813 | 0.200 |
Why?
|
| Paralysis | 1 | 2022 | 249 | 0.200 |
Why?
|
| Hip Fractures | 2 | 2019 | 954 | 0.170 |
Why?
|
| Streptococcus pyogenes | 1 | 2021 | 289 | 0.170 |
Why?
|
| Arthrometry, Articular | 1 | 2018 | 17 | 0.170 |
Why?
|
| Bone Screws | 2 | 2021 | 519 | 0.160 |
Why?
|
| Ankle | 1 | 2021 | 327 | 0.160 |
Why?
|
| Femoral Neck Fractures | 1 | 2019 | 138 | 0.150 |
Why?
|
| Wounds, Gunshot | 1 | 2023 | 562 | 0.150 |
Why?
|
| Hematoma | 1 | 2022 | 755 | 0.150 |
Why?
|
| Bone Nails | 1 | 2019 | 219 | 0.150 |
Why?
|
| Radiography | 5 | 2019 | 7010 | 0.150 |
Why?
|
| Fracture Fixation | 2 | 2008 | 354 | 0.130 |
Why?
|
| Unnecessary Procedures | 1 | 2019 | 431 | 0.130 |
Why?
|
| Bacterial Infections | 1 | 2024 | 1389 | 0.130 |
Why?
|
| Fractures, Ununited | 1 | 2016 | 165 | 0.130 |
Why?
|
| Arthroplasty, Replacement | 1 | 1999 | 336 | 0.120 |
Why?
|
| Postpartum Period | 1 | 2021 | 1078 | 0.120 |
Why?
|
| Bone Neoplasms | 4 | 2014 | 2522 | 0.120 |
Why?
|
| Models, Anatomic | 1 | 2018 | 690 | 0.120 |
Why?
|
| Postoperative Period | 1 | 2019 | 1839 | 0.120 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2019 | 721 | 0.120 |
Why?
|
| Smad Proteins | 1 | 2014 | 162 | 0.120 |
Why?
|
| Tibia | 3 | 2023 | 1075 | 0.110 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2024 | 1457 | 0.110 |
Why?
|
| Surgical Wound Infection | 1 | 2022 | 1538 | 0.110 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2014 | 472 | 0.100 |
Why?
|
| Hospitalization | 1 | 2011 | 10232 | 0.100 |
Why?
|
| Humans | 32 | 2024 | 742088 | 0.100 |
Why?
|
| Inflammation | 1 | 2010 | 10578 | 0.090 |
Why?
|
| Bone Diseases | 1 | 2014 | 416 | 0.090 |
Why?
|
| Retrospective Studies | 10 | 2024 | 77098 | 0.090 |
Why?
|
| Compressive Strength | 1 | 2010 | 169 | 0.090 |
Why?
|
| Treatment Outcome | 7 | 2024 | 62966 | 0.090 |
Why?
|
| Cadaver | 2 | 2010 | 1333 | 0.090 |
Why?
|
| Therapeutic Irrigation | 1 | 2010 | 300 | 0.090 |
Why?
|
| Integrins | 1 | 2014 | 845 | 0.090 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2009 | 144 | 0.080 |
Why?
|
| Sulfides | 1 | 2009 | 166 | 0.080 |
Why?
|
| Chondrogenesis | 1 | 2010 | 247 | 0.080 |
Why?
|
| Leukotriene B4 | 1 | 2009 | 293 | 0.080 |
Why?
|
| Muscle, Skeletal | 1 | 2023 | 4933 | 0.080 |
Why?
|
| Hydroxyurea | 1 | 2009 | 290 | 0.080 |
Why?
|
| Acetates | 1 | 2009 | 312 | 0.080 |
Why?
|
| Cyclopropanes | 1 | 2009 | 416 | 0.080 |
Why?
|
| Linear Models | 1 | 2018 | 5948 | 0.080 |
Why?
|
| Hydroxamic Acids | 1 | 2010 | 495 | 0.080 |
Why?
|
| Hypertrophy | 1 | 2009 | 568 | 0.080 |
Why?
|
| Orthotic Devices | 1 | 2008 | 128 | 0.070 |
Why?
|
| Anticoagulants | 1 | 2022 | 4595 | 0.070 |
Why?
|
| Osteoblasts | 2 | 2009 | 1163 | 0.070 |
Why?
|
| Bone Resorption | 1 | 2010 | 722 | 0.070 |
Why?
|
| Fractures, Compression | 1 | 2008 | 134 | 0.070 |
Why?
|
| Pelvic Bones | 1 | 2008 | 265 | 0.070 |
Why?
|
| Models, Theoretical | 1 | 2018 | 3584 | 0.070 |
Why?
|
| Adult | 8 | 2024 | 213712 | 0.070 |
Why?
|
| Antigens, Neoplasm | 1 | 2014 | 1983 | 0.070 |
Why?
|
| Prostatic Neoplasms | 3 | 2014 | 11039 | 0.070 |
Why?
|
| Transcriptional Activation | 2 | 2009 | 1782 | 0.070 |
Why?
|
| Bone Remodeling | 1 | 2009 | 575 | 0.070 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2010 | 789 | 0.070 |
Why?
|
| Mice, SCID | 4 | 2014 | 2715 | 0.060 |
Why?
|
| Organizational Innovation | 1 | 2008 | 559 | 0.060 |
Why?
|
| Quinolines | 1 | 2009 | 719 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2014 | 4211 | 0.060 |
Why?
|
| Bone Plates | 2 | 2024 | 467 | 0.060 |
Why?
|
| Pelvis | 1 | 2008 | 730 | 0.060 |
Why?
|
| Hedgehog Proteins | 1 | 2008 | 781 | 0.060 |
Why?
|
| Societies, Medical | 1 | 2015 | 3740 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 3611 | 0.060 |
Why?
|
| Bone Wires | 1 | 2003 | 122 | 0.060 |
Why?
|
| Cartilage, Articular | 1 | 2010 | 1095 | 0.060 |
Why?
|
| Female | 9 | 2022 | 379592 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 14720 | 0.060 |
Why?
|
| Tarsal Bones | 1 | 2003 | 65 | 0.050 |
Why?
|
| Myography | 1 | 2023 | 109 | 0.050 |
Why?
|
| Reoperation | 2 | 2023 | 4200 | 0.050 |
Why?
|
| Animals | 12 | 2024 | 168561 | 0.050 |
Why?
|
| Metatarsal Bones | 1 | 2003 | 107 | 0.050 |
Why?
|
| Workload | 1 | 2008 | 849 | 0.050 |
Why?
|
| Cell Proliferation | 4 | 2010 | 10472 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 1675 | 0.050 |
Why?
|
| Joints | 1 | 2003 | 326 | 0.050 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 57683 | 0.050 |
Why?
|
| Mice | 9 | 2023 | 81045 | 0.050 |
Why?
|
| Knee Injuries | 1 | 2005 | 490 | 0.050 |
Why?
|
| Male | 12 | 2022 | 349538 | 0.050 |
Why?
|
| Extremities | 2 | 2019 | 865 | 0.050 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 8621 | 0.040 |
Why?
|
| Parathyroid Hormone-Related Protein | 2 | 2014 | 331 | 0.040 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2008 | 1009 | 0.040 |
Why?
|
| Aged | 8 | 2023 | 162944 | 0.040 |
Why?
|
| Electric Impedance | 1 | 2023 | 727 | 0.040 |
Why?
|
| Pregnancy | 1 | 2021 | 29087 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2021 | 40955 | 0.040 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2023 | 638 | 0.040 |
Why?
|
| Tourniquets | 1 | 2019 | 110 | 0.040 |
Why?
|
| Models, Biological | 3 | 2009 | 9581 | 0.040 |
Why?
|
| Financial Support | 1 | 1999 | 115 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 7276 | 0.040 |
Why?
|
| Disease Progression | 2 | 2014 | 13256 | 0.040 |
Why?
|
| Ilizarov Technique | 1 | 2016 | 12 | 0.040 |
Why?
|
| Equipment Failure | 1 | 2019 | 579 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2019 | 867 | 0.030 |
Why?
|
| Equipment and Supplies | 1 | 1999 | 281 | 0.030 |
Why?
|
| Pressure | 1 | 2019 | 1203 | 0.030 |
Why?
|
| Cell Line, Tumor | 4 | 2014 | 16665 | 0.030 |
Why?
|
| Signal Transduction | 3 | 2014 | 23387 | 0.030 |
Why?
|
| Osteoclasts | 2 | 2009 | 729 | 0.030 |
Why?
|
| Ischemia | 1 | 2023 | 1911 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2009 | 12071 | 0.030 |
Why?
|
| Conflict of Interest | 1 | 1999 | 542 | 0.030 |
Why?
|
| Bacteria | 1 | 2024 | 2102 | 0.030 |
Why?
|
| Bone and Bones | 2 | 2016 | 2575 | 0.030 |
Why?
|
| Osteopontin | 1 | 2014 | 296 | 0.030 |
Why?
|
| Drug Industry | 1 | 1999 | 744 | 0.030 |
Why?
|
| Interprofessional Relations | 1 | 1999 | 1008 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2009 | 7873 | 0.030 |
Why?
|
| Age Factors | 1 | 2008 | 18355 | 0.030 |
Why?
|
| Physician's Role | 1 | 1999 | 942 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2016 | 1684 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2014 | 902 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2014 | 638 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2014 | 644 | 0.020 |
Why?
|
| Equipment Design | 2 | 2008 | 3582 | 0.020 |
Why?
|
| Middle Aged | 4 | 2019 | 213127 | 0.020 |
Why?
|
| Bony Callus | 1 | 2009 | 36 | 0.020 |
Why?
|
| Data Collection | 1 | 1999 | 3339 | 0.020 |
Why?
|
| Genes, bcl-1 | 1 | 2008 | 11 | 0.020 |
Why?
|
| Acute Disease | 1 | 2019 | 7141 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2009 | 553 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 2014 | 1057 | 0.020 |
Why?
|
| United States | 2 | 2015 | 69693 | 0.020 |
Why?
|
| Rats | 1 | 2023 | 24265 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 5385 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2008 | 504 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 7153 | 0.020 |
Why?
|
| Cartilage | 1 | 2009 | 818 | 0.020 |
Why?
|
| Homeostasis | 1 | 2016 | 3335 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2009 | 721 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 1655 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2010 | 1905 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2008 | 2335 | 0.020 |
Why?
|
| Fluoroscopy | 1 | 2008 | 924 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2009 | 8425 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2010 | 3557 | 0.010 |
Why?
|
| Young Adult | 1 | 2008 | 56350 | 0.010 |
Why?
|
| Injury Severity Score | 1 | 2005 | 1013 | 0.010 |
Why?
|
| Soft Tissue Injuries | 1 | 2003 | 176 | 0.010 |
Why?
|
| Models, Animal | 1 | 2008 | 2170 | 0.010 |
Why?
|
| User-Computer Interface | 1 | 2008 | 1426 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 20774 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2023 | 15244 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 2006 | 0.010 |
Why?
|
| Adolescent | 1 | 2008 | 85649 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2008 | 6313 | 0.010 |
Why?
|
| Prostheses and Implants | 1 | 2008 | 1385 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2009 | 2504 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2008 | 2382 | 0.010 |
Why?
|
| Probability | 1 | 2005 | 2502 | 0.010 |
Why?
|
| Accidents, Traffic | 1 | 2005 | 819 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 3504 | 0.010 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2009 | 1625 | 0.010 |
Why?
|
| Tumor Microenvironment | 1 | 2010 | 3564 | 0.010 |
Why?
|
| Cell Movement | 1 | 2009 | 5212 | 0.010 |
Why?
|
| Accidental Falls | 1 | 2005 | 1057 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2005 | 3418 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2005 | 2924 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2009 | 14554 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2008 | 5851 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2009 | 11470 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 18006 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 19862 | 0.010 |
Why?
|
| Time Factors | 1 | 2009 | 40054 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2008 | 20086 | 0.000 |
Why?
|
| Risk Assessment | 1 | 2005 | 23320 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2005 | 39004 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2005 | 40450 | 0.000 |
Why?
|
Concepts
(220)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(26)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_